Phase 2 B-cell NHL Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Hodgkin LymphomaB-cell LymphomaRelapsed B-cell NHL

M.D. Anderson Cancer Center36 enrolled1 locationNCT05615636

Recruiting

Phase 1Phase 2

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

CLLB-cell NHL

Fondazione Matilde Tettamanti Menotti De Marchi Onlus29 enrolled1 locationNCT05869279